Formylglycine-generating enzyme (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Formylglycine-generating enzyme" in English language version.

refsWebsite

Global rank English rank

29nih.gov

4^th place

15doi.org

2^nd place

doi.org

Roeser D, Dickmanns A, Gasow K, Rudolph MG (August 2005). "De novo calcium/sulfur SAD phasing of the human formylglycine-generating enzyme using in-house data". Acta Crystallographica. Section D, Biological Crystallography. 61 (Pt 8): 1057–66. doi:10.1107/S0907444905013831. PMID 16041070.
Knop M, Dang TQ, Jeschke G, Seebeck FP (January 2017). "Copper is a Cofactor of the Formylglycine-Generating Enzyme". ChemBioChem. 18 (2): 161–165. doi:10.1002/cbic.201600359. PMC 5324649. PMID 27862795.
Appel MJ, Meier KK, Lafrance-Vanasse J, Lim H, Tsai CL, Hedman B, et al. (March 2019). "2 activation". Proceedings of the National Academy of Sciences of the United States of America. 116 (12): 5370–5375. doi:10.1073/pnas.1818274116. PMC 6431200. PMID 30824597.
Miarzlou DA, Leisinger F, Joss D, Häussinger D, Seebeck FP (August 2019). "Structure of formylglycine-generating enzyme in complex with copper and a substrate reveals an acidic pocket for binding and activation of molecular oxygen". Chemical Science. 10 (29): 7049–7058. doi:10.1039/C9SC01723B. PMC 6676471. PMID 31588272.
Appel MJ, Bertozzi CR (January 2015). "Formylglycine, a post-translationally generated residue with unique catalytic capabilities and biotechnology applications". ACS Chemical Biology. 10 (1): 72–84. doi:10.1021/cb500897w. PMC 4492166. PMID 25514000.
Benjdia A, Leprince J, Guillot A, Vaudry H, Rabot S, Berteau O (March 2007). "Anaerobic sulfatase-maturating enzymes: radical SAM enzymes able to catalyze in vitro sulfatase post-translational modification". Journal of the American Chemical Society. 129 (12): 3462–3. doi:10.1021/ja067175e. PMID 17335281.
Carlson BL, Ballister ER, Skordalakes E, King DS, Breidenbach MA, Gilmore SA, et al. (July 2008). "Function and structure of a prokaryotic formylglycine-generating enzyme". The Journal of Biological Chemistry. 283 (29): 20117–25. doi:10.1074/jbc.M800217200. PMC 2459300. PMID 18390551.
Appel MJ, Bertozzi CR (January 2015). "Formylglycine, a post-translationally generated residue with unique catalytic capabilities and biotechnology applications". ACS Chemical Biology. 10 (1): 72–84. doi:10.1021/cb500897w. PMC 4492166. PMID 25514000.
Fraldi A, Biffi A, Lombardi A, Visigalli I, Pepe S, Settembre C, et al. (April 2007). "SUMF1 enhances sulfatase activities in vivo in five sulfatase deficiencies". The Biochemical Journal. 403 (2): 305–12. doi:10.1042/BJ20061783. PMC 1874239. PMID 17206939.
Diez-Roux G, Ballabio A (2005). "Sulfatases and human disease". Annual Review of Genomics and Human Genetics. 6: 355–79. doi:10.1146/annurev.genom.6.080604.162334. PMID 16124866.
Sardiello M, Annunziata I, Roma G, Ballabio A (November 2005). "Sulfatases and sulfatase modifying factors: an exclusive and promiscuous relationship". Human Molecular Genetics. 14 (21): 3203–17. doi:10.1093/hmg/ddi351. PMID 16174644.
Schlotawa L, Ennemann EC, Radhakrishnan K, Schmidt B, Chakrapani A, Christen HJ, et al. (March 2011). "SUMF1 mutations affecting stability and activity of formylglycine generating enzyme predict clinical outcome in multiple sulfatase deficiency". European Journal of Human Genetics. 19 (3): 253–61. doi:10.1038/ejhg.2010.219. PMC 3062010. PMID 21224894.
Staretz-Chacham O, Schlotawa L, Wormser O, Golan-Tripto I, Birk OS, Ferreira CR, et al. (September 2020). "A homozygous missense variant of SUMF1 in the Bedouin population extends the clinical spectrum in ultrarare neonatal multiple sulfatase deficiency". Molecular Genetics & Genomic Medicine. 8 (9): e1167. doi:10.1002/mgg3.1167. PMC 7507568. PMID 32048457.
Weidner J, Jarenbäck L, de Jong K, Vonk JM, van den Berge M, Brandsma CA, et al. (May 2017). "Sulfatase modifying factor 1 (SUMF1) is associated with Chronic Obstructive Pulmonary Disease". Respiratory Research. 18 (1): 77. doi:10.1186/s12931-017-0562-5. PMC 5414362. PMID 28464818.
Staretz-Chacham O, Schlotawa L, Wormser O, Golan-Tripto I, Birk OS, Ferreira CR, et al. (September 2020). "A homozygous missense variant of SUMF1 in the Bedouin population extends the clinical spectrum in ultrarare neonatal multiple sulfatase deficiency". Molecular Genetics & Genomic Medicine. 8 (9): e1167. doi:10.1002/mgg3.1167. PMC 7507568. PMID 32048457.

nih.gov

pubmed.ncbi.nlm.nih.gov

Roeser D, Dickmanns A, Gasow K, Rudolph MG (August 2005). "De novo calcium/sulfur SAD phasing of the human formylglycine-generating enzyme using in-house data". Acta Crystallographica. Section D, Biological Crystallography. 61 (Pt 8): 1057–66. doi:10.1107/S0907444905013831. PMID 16041070.
Knop M, Dang TQ, Jeschke G, Seebeck FP (January 2017). "Copper is a Cofactor of the Formylglycine-Generating Enzyme". ChemBioChem. 18 (2): 161–165. doi:10.1002/cbic.201600359. PMC 5324649. PMID 27862795.
Appel MJ, Meier KK, Lafrance-Vanasse J, Lim H, Tsai CL, Hedman B, et al. (March 2019). "2 activation". Proceedings of the National Academy of Sciences of the United States of America. 116 (12): 5370–5375. doi:10.1073/pnas.1818274116. PMC 6431200. PMID 30824597.
Miarzlou DA, Leisinger F, Joss D, Häussinger D, Seebeck FP (August 2019). "Structure of formylglycine-generating enzyme in complex with copper and a substrate reveals an acidic pocket for binding and activation of molecular oxygen". Chemical Science. 10 (29): 7049–7058. doi:10.1039/C9SC01723B. PMC 6676471. PMID 31588272.
Appel MJ, Bertozzi CR (January 2015). "Formylglycine, a post-translationally generated residue with unique catalytic capabilities and biotechnology applications". ACS Chemical Biology. 10 (1): 72–84. doi:10.1021/cb500897w. PMC 4492166. PMID 25514000.
Benjdia A, Leprince J, Guillot A, Vaudry H, Rabot S, Berteau O (March 2007). "Anaerobic sulfatase-maturating enzymes: radical SAM enzymes able to catalyze in vitro sulfatase post-translational modification". Journal of the American Chemical Society. 129 (12): 3462–3. doi:10.1021/ja067175e. PMID 17335281.
Carlson BL, Ballister ER, Skordalakes E, King DS, Breidenbach MA, Gilmore SA, et al. (July 2008). "Function and structure of a prokaryotic formylglycine-generating enzyme". The Journal of Biological Chemistry. 283 (29): 20117–25. doi:10.1074/jbc.M800217200. PMC 2459300. PMID 18390551.
Appel MJ, Bertozzi CR (January 2015). "Formylglycine, a post-translationally generated residue with unique catalytic capabilities and biotechnology applications". ACS Chemical Biology. 10 (1): 72–84. doi:10.1021/cb500897w. PMC 4492166. PMID 25514000.
Fraldi A, Biffi A, Lombardi A, Visigalli I, Pepe S, Settembre C, et al. (April 2007). "SUMF1 enhances sulfatase activities in vivo in five sulfatase deficiencies". The Biochemical Journal. 403 (2): 305–12. doi:10.1042/BJ20061783. PMC 1874239. PMID 17206939.
Diez-Roux G, Ballabio A (2005). "Sulfatases and human disease". Annual Review of Genomics and Human Genetics. 6: 355–79. doi:10.1146/annurev.genom.6.080604.162334. PMID 16124866.
Sardiello M, Annunziata I, Roma G, Ballabio A (November 2005). "Sulfatases and sulfatase modifying factors: an exclusive and promiscuous relationship". Human Molecular Genetics. 14 (21): 3203–17. doi:10.1093/hmg/ddi351. PMID 16174644.
Schlotawa L, Ennemann EC, Radhakrishnan K, Schmidt B, Chakrapani A, Christen HJ, et al. (March 2011). "SUMF1 mutations affecting stability and activity of formylglycine generating enzyme predict clinical outcome in multiple sulfatase deficiency". European Journal of Human Genetics. 19 (3): 253–61. doi:10.1038/ejhg.2010.219. PMC 3062010. PMID 21224894.
Staretz-Chacham O, Schlotawa L, Wormser O, Golan-Tripto I, Birk OS, Ferreira CR, et al. (September 2020). "A homozygous missense variant of SUMF1 in the Bedouin population extends the clinical spectrum in ultrarare neonatal multiple sulfatase deficiency". Molecular Genetics & Genomic Medicine. 8 (9): e1167. doi:10.1002/mgg3.1167. PMC 7507568. PMID 32048457.
Weidner J, Jarenbäck L, de Jong K, Vonk JM, van den Berge M, Brandsma CA, et al. (May 2017). "Sulfatase modifying factor 1 (SUMF1) is associated with Chronic Obstructive Pulmonary Disease". Respiratory Research. 18 (1): 77. doi:10.1186/s12931-017-0562-5. PMC 5414362. PMID 28464818.
Staretz-Chacham O, Schlotawa L, Wormser O, Golan-Tripto I, Birk OS, Ferreira CR, et al. (September 2020). "A homozygous missense variant of SUMF1 in the Bedouin population extends the clinical spectrum in ultrarare neonatal multiple sulfatase deficiency". Molecular Genetics & Genomic Medicine. 8 (9): e1167. doi:10.1002/mgg3.1167. PMC 7507568. PMID 32048457.

ncbi.nlm.nih.gov

Knop M, Dang TQ, Jeschke G, Seebeck FP (January 2017). "Copper is a Cofactor of the Formylglycine-Generating Enzyme". ChemBioChem. 18 (2): 161–165. doi:10.1002/cbic.201600359. PMC 5324649. PMID 27862795.
Appel MJ, Meier KK, Lafrance-Vanasse J, Lim H, Tsai CL, Hedman B, et al. (March 2019). "2 activation". Proceedings of the National Academy of Sciences of the United States of America. 116 (12): 5370–5375. doi:10.1073/pnas.1818274116. PMC 6431200. PMID 30824597.
Miarzlou DA, Leisinger F, Joss D, Häussinger D, Seebeck FP (August 2019). "Structure of formylglycine-generating enzyme in complex with copper and a substrate reveals an acidic pocket for binding and activation of molecular oxygen". Chemical Science. 10 (29): 7049–7058. doi:10.1039/C9SC01723B. PMC 6676471. PMID 31588272.
Appel MJ, Bertozzi CR (January 2015). "Formylglycine, a post-translationally generated residue with unique catalytic capabilities and biotechnology applications". ACS Chemical Biology. 10 (1): 72–84. doi:10.1021/cb500897w. PMC 4492166. PMID 25514000.
Carlson BL, Ballister ER, Skordalakes E, King DS, Breidenbach MA, Gilmore SA, et al. (July 2008). "Function and structure of a prokaryotic formylglycine-generating enzyme". The Journal of Biological Chemistry. 283 (29): 20117–25. doi:10.1074/jbc.M800217200. PMC 2459300. PMID 18390551.
Appel MJ, Bertozzi CR (January 2015). "Formylglycine, a post-translationally generated residue with unique catalytic capabilities and biotechnology applications". ACS Chemical Biology. 10 (1): 72–84. doi:10.1021/cb500897w. PMC 4492166. PMID 25514000.
Fraldi A, Biffi A, Lombardi A, Visigalli I, Pepe S, Settembre C, et al. (April 2007). "SUMF1 enhances sulfatase activities in vivo in five sulfatase deficiencies". The Biochemical Journal. 403 (2): 305–12. doi:10.1042/BJ20061783. PMC 1874239. PMID 17206939.
Schlotawa L, Ennemann EC, Radhakrishnan K, Schmidt B, Chakrapani A, Christen HJ, et al. (March 2011). "SUMF1 mutations affecting stability and activity of formylglycine generating enzyme predict clinical outcome in multiple sulfatase deficiency". European Journal of Human Genetics. 19 (3): 253–61. doi:10.1038/ejhg.2010.219. PMC 3062010. PMID 21224894.
Staretz-Chacham O, Schlotawa L, Wormser O, Golan-Tripto I, Birk OS, Ferreira CR, et al. (September 2020). "A homozygous missense variant of SUMF1 in the Bedouin population extends the clinical spectrum in ultrarare neonatal multiple sulfatase deficiency". Molecular Genetics & Genomic Medicine. 8 (9): e1167. doi:10.1002/mgg3.1167. PMC 7507568. PMID 32048457.
Weidner J, Jarenbäck L, de Jong K, Vonk JM, van den Berge M, Brandsma CA, et al. (May 2017). "Sulfatase modifying factor 1 (SUMF1) is associated with Chronic Obstructive Pulmonary Disease". Respiratory Research. 18 (1): 77. doi:10.1186/s12931-017-0562-5. PMC 5414362. PMID 28464818.
Staretz-Chacham O, Schlotawa L, Wormser O, Golan-Tripto I, Birk OS, Ferreira CR, et al. (September 2020). "A homozygous missense variant of SUMF1 in the Bedouin population extends the clinical spectrum in ultrarare neonatal multiple sulfatase deficiency". Molecular Genetics & Genomic Medicine. 8 (9): e1167. doi:10.1002/mgg3.1167. PMC 7507568. PMID 32048457.

ghr.nlm.nih.gov

Reference, Genetics Home. "SUMF1 gene". Genetics Home Reference. Retrieved 2020-03-27.
Reference, Genetics Home. "SUMF1 gene". Genetics Home Reference. Retrieved 2020-03-27.
Reference, Genetics Home. "SUMF1 gene". Genetics Home Reference. Retrieved 2020-03-27.